Trade JnJ ^JNJ

Contineum Therapeutics Reports Phase 2 Results for JNJ-5120/PIPE-307 for the Treatment of Major Depressive Disorder | Morningstar

Apollo rumoured to be eyeing $20bn takeover of J&J's orthopaedics business

Top Pharmaceutical Stocks To Research - September 14th - Daily Political

Johnson & Johnson Targets Double-Digit Growth as STELARA Faces Biosimilar Competition - Daily Political

J&J's RYBREVANT Plus Chemotherapy Sets New Benchmark In EGFR Exon 20 Insertion NSCLC Survival

Zacks Investment Ideas feature highlights: Johnson & Johnson, Coca-Cola and Exxon Mobil

Compass Financial Management LLC Invests $1.42 Million in Johnson & Johnson $JNJ

Bank of America Corp DE Sells 2,078,556 Shares of Johnson & Johnson $JNJ

Azimuth Capital Investment Management LLC Sells 3,870 Shares of Johnson & Johnson $JNJ

Pharmaceutical Stocks To Keep An Eye On - September 13th - Daily Political

Johnson & Johnson $JNJ Shares Bought by Concurrent Investment Advisors LLC

Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC

The Closest Thing to Set-It-and-Forget-It Income: 5 Dividend Kings for Retirees Who Want Peace of Mind

Pharmaceutical Stocks To Follow Today - September 12th - Stock Observer

PYA Waltman Capital LLC Has $11.44 Million Position in Johnson & Johnson $JNJ - Markets Daily

Burford Brothers Inc. Decreases Stake in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Stock Holdings Lifted by PYA Waltman Capital LLC - Stock Observer

J&J orthopedics unit draws Apollo interest in potential $20 billion deal: Report - The Economic Times

Apollo Global in talks to buy J&J's orthopedics unit, Bloomberg reports

Apollo Global Is Said in Talks to Acquire J&J's Orthopedics Unit

Is AbbVie Stock Actually Overpriced?

Meet Ottava, J&J's surgical robot leading the healthcare giant into a lucrative new market

3 Top Dividend Aristocrats To Own Near All-Time Highs

Johnson & Johnson (NYSE:JNJ) Receives Consensus Rating of "Moderate Buy" from Brokerages - Zolmax

J&J's new reusable contact lens secures CE Mark

Rinkey Investments Reduces Holdings in Johnson & Johnson $JNJ

Proficio Capital Partners LLC Boosts Position in Johnson & Johnson $JNJ

Proficio Capital Partners LLC Increases Stock Position in Johnson & Johnson $JNJ - Markets Daily

Lone Peak Global Investors LLC Decreases Holdings in Johnson & Johnson $JNJ

New Technologies and Achievements Make Concentrated Debuts, Highlighting CIFTIS as a Platform for Innovation | AsiaNet

RBC Capital Sticks to Its Buy Rating for Johnson & Johnson (JNJ)

Johnson & Johnson $JNJ Shares Sold by XML Financial LLC - Daily Political

Rinkey Investments Cuts Stake in Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson Receives CE Marking For ACUVUE OASYS MAX 2-Week Contact Lenses

J&J names two-decade veteran as chief IP counsel | Careers | Life Sciences Intellectual Property Review

J&J unit win shuts door on Sandoz generic launch | Pharma | Life Sciences Intellectual Property Review

Johnson & Johnson $JNJ Shares Sold by Meiji Yasuda Life Insurance Co - Zolmax

Nichols & Pratt Advisers LLP MA Lowers Holdings in Johnson & Johnson $JNJ

Montanova Capital LLC Has $1.96 Million Position in Johnson & Johnson $JNJ

Sigma Planning Corp Boosts Stock Holdings in Johnson & Johnson $JNJ

Northwestern Mutual Wealth Management Co. Has $93.80 Million Stock Holdings in Johnson & Johnson $JNJ

Ancora Advisors LLC Sells 21,326 Shares of Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Sold by Meiji Yasuda Life Insurance Co - Daily Political

Multiple Myeloma Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation by 2036 - DelveInsight | Regeneron, Sanofi, Arcellx, Gilead, AbbVie, Bristol-Myers Squibb | ABNewswire

Glanbia selects Chang Smith as new CFO

Could Icotyde Become Johnson & Johnson's Next Blockbuster in China?

Paying Off the House With Your 401(k) Feels Smart but Can Cost Six Figures. These 3 ETFs Are Why You Keep the Money Invested

Health Care Down, but Not by Much, on Defensive Bias - Health Care Roundup | Morningstar

Jim Cramer Picks J&J (JNJ) Over Eli Lilly (LLY) and Pfizer (PFE) Among These Healthcare Stocks

Johnson & Johnson Eyes High-End MedTech Growth as Cardiovascular Takes Center Stage

Johnson & Johnson $JNJ Shares Sold by Royal London Asset Management Ltd. - Markets Daily

Navellier & Associates Inc. Has $4.31 Million Stake in Johnson & Johnson $JNJ

Navellier & Associates Inc. Has $4.31 Million Stock Holdings in Johnson & Johnson $JNJ - Zolmax

Greenwood Capital Associates LLC Has $9.65 Million Position in Johnson & Johnson $JNJ

Ferguson Wellman Capital Management Inc. Buys 3,742 Shares of Johnson & Johnson $JNJ

Royal London Asset Management Ltd. Sells 13,216 Shares of Johnson & Johnson $JNJ - Stock Observer

Nissay Asset Management Corp Japan Buys 10,489 Shares of Johnson & Johnson $JNJ - Stock Observer

Brokerages Set Johnson & Johnson (NYSE:JNJ) PT at $272.83 - Daily Political

Mufg Securities Americas Inc. Buys 5,833 Shares of Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson (JNJ) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Johnson & Johnson (NYSE:JNJ) Shares Down 2.3% - Time to Sell?

Want Dividends to Pay Your Medicare Premiums? Here's How Much You Need

JEPI Is an Income Machine-But These 3 Dividend Stocks Don't Cap Your Upside

4,101 Shares in Johnson & Johnson $JNJ Purchased by Yukon Wealth Management Inc.

Assessment of the Pulmonary Arterial Hypertension (PAH) Market 2026-2036 Featuring United Therapeutics, Mochida Pharmaceutical, Johnson & Johnson, Merck, and Gossamer Bio

Rakuten Investment Management Inc. Increases Stock Position in Johnson & Johnson $JNJ

Jefferies Financial Group Inc. Has $17.27 Million Stock Position in Johnson & Johnson $JNJ

Empowered Funds LLC Purchases 36,477 Shares of Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Sold by Equitable Holdings Inc.

Yukon Wealth Management Inc. Invests $1.04 Million in Johnson & Johnson $JNJ - Stock Observer

United Capital Financial Advisors LLC Has $87.75 Million Stake in Johnson & Johnson $JNJ - Daily Political

Lilly vs. J&J: Betting on Breakout Growth or Built-In Stability?

Pharmaceutical Stocks To Watch Today - September 7th - Stock Observer

Which Defensive Stock Has Dominated in 2026: Coca-Cola, Johnson & Johnson, or Procter & Gamble?

Caisse de depot et placement du Quebec Sells 726,280 Shares of Johnson & Johnson $JNJ

Freestone Grove Partners LP Sells 37,143 Shares of Johnson & Johnson $JNJ

Fayez Sarofim & Co Has $174.87 Million Stake in Johnson & Johnson $JNJ

EFG International AG Lowers Stake in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Shares Acquired by Corient Private Wealth LP

Johnson & Johnson $JNJ is Stonebridge Capital Management Inc.'s 7th Largest Position - Stock Observer

Proficio Capital Partners LLC Has $2.68 Million Holdings in Johnson & Johnson $JNJ - Daily Political

Johnson & Johnson (NYSE:JNJ) versus CASI Pharmaceuticals (NASDAQ:CASI) Critical Review - Markets Daily

Legal & General Group Plc Sells 60,958 Shares of Johnson & Johnson $JNJ

Jones Financial Companies Lllp Grows Stock Position in Johnson & Johnson $JNJ

Van Hulzen Asset Management LLC Sells 4,943 Shares of Johnson & Johnson $JNJ

Peak Asset Management LLC Increases Stock Position in Johnson & Johnson $JNJ

The Manufacturers Life Insurance Company Increases Stake in Johnson & Johnson $JNJ

Trajan Wealth LLC Has $10.13 Million Stake in Johnson & Johnson $JNJ

Canada Pension Plan Investment Board Buys 739,792 Shares of Johnson & Johnson $JNJ

Johnson & Johnson $JNJ is Cullen Capital Management LLC's 4th Largest Position

Johnson & Johnson $JNJ Shares Sold by Manning & Napier Advisors LLC - Stock Observer

 Week Ahead: Inflation Data from U.S., Canada, and U.K. Take Centre Stage

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

Week Ahead: BoC and ECB Interest Rate Decisions in Focus This Week

Week ahead: ECB set to cut as Wall Street earnings season gathers pace

Week ahead: US earnings season kicks off, ECB hold expected

Europe Tries to Ride on US Coat-tails

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk